Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR)

Q: What does CUSIP 17322U306 represent in this 13F holders report?

CUSIP 17322U306 is the security identifier for CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in Q2 2025?

31 institutional investors reported CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 17322U306

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 24,189,141
Total 13F shares: 928,766
Share change: +293,293
Total reported value: $1,477,067
Put/Call ratio: 90%
Price per share: $1.59
Number of holders: 31
Value change: +$473,599
Number of buys: 14
Number of sells: 10

Quarterly Holders Quick Answers

What is CUSIP 17322U306?
CUSIP 17322U306 identifies CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 17322U306:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Top shareholders of CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	1.1%	257,631	$383,870	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	89,275	$133,047	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.3%	72,227	$107,618	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.28%	67,215	$100,151	—	31 Mar 2025	13F
Squarepoint Ops LLC	13F	Company	0.25%	60,983	$90,865	—	31 Mar 2025	13F
Jaime Bartushak	3/4/5	Chief Financial Officer	— mixed-class rows	410,353 mixed-class rows	$45,265	—	07 Nov 2024	3/4/5
STATE STREET CORP	13F	Company	0.1%	23,271	$34,674	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.06%	15,173	$22,608	—	31 Mar 2025	13F
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors	13F	Company	0.06%	14,000	$21,700	—	31 Mar 2025	13F
Arkadios Wealth Advisors	13F	Company	0.04%	10,000	$14,900	—	31 Mar 2025	13F
IFP Advisors, Inc	13F	Company	0.03%	7,083	$10,554	—	31 Mar 2025	13F
Carol Webb	3/4/5	Director	— mixed-class rows	136,835 mixed-class rows	$8,876	—	07 Nov 2024	3/4/5
CHELSEA COUNSEL CO	13F	Company	0.02%	4,626	$6,893	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	4,410	$6,571	—	31 Mar 2025	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	3,342	$4,980	—	31 Mar 2025	13F
SBI Securities Co., Ltd.	13F	Company	0.01%	2,268	$3,379	—	31 Mar 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	1,527	$2,274	—	31 Mar 2025	13F
Eugene Myron Holuka	3/4/5	Director	— mixed-class rows	127,367 mixed-class rows	$1,775	—	07 Nov 2024	3/4/5
SIMPLEX TRADING, LLC	13F	Company	0%	966	$1,000	—	31 Mar 2025	13F
Luminist Capital LLC	13F	Company	0%	435	$522	—	31 Mar 2025	13F
Murphy & Mullick Capital Management Corp	13F	Company	0%	160	$238	—	31 Mar 2025	13F
Princeton Global Asset Management LLC	13F	Company	0%	160	$238	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	136	$203	—	31 Mar 2025	13F
Smallwood Wealth Investment Management, LLC	13F	Company	0%	120	$178	—	31 Mar 2025	13F
Quent Capital, LLC	13F	Company	0%	108	$161	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	107	$159	—	31 Mar 2025	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	80	$119	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	68	$101	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0%	60	$89	—	31 Mar 2025	13F
Fairscale Capital, LLC	13F	Company	0%	42	$63	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0%	29	$43	—	31 Mar 2025	13F
Myron Czuczman	3/4/5	Chief Medical Officer	— class O/S missing	300,000	—	—	07 Nov 2024	3/4/5
Dennis M. Mcgrath	3/4/5	Director	— class O/S missing	125,000	—	—	07 Nov 2024	3/4/5
Robert Joseph Smith	3/4/5	Director	— class O/S missing	125,000	—	—	07 Nov 2024	3/4/5
Suren G. Dutia	3/4/5	Director	— class O/S missing	125,000	—	—	07 Nov 2024	3/4/5
Howard Safir	3/4/5	Director	— class O/S missing	75,000	—	—	04 Oct 2022	3/4/5
William Kane	3/4/5	Director	— class O/S missing	75,000	—	—	04 Oct 2022	3/4/5

Institutional Holders of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) as of Q2 2025

As of 30 Jun 2025, Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 928,766 shares. The largest 10 holders included UBS Group AG, Cambridge Investment Research Advisors, Inc., HEIGHTS CAPITAL MANAGEMENT, INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., NewEdge Advisors, LLC, STATE STREET CORP, XTX Topco Ltd, and Arkadios Wealth Advisors. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.